Methods and compositions of novel triazine compounds

The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associ...

Full description

Saved in:
Bibliographic Details
Main Authors SAXENA UDAY, TIMMER RICHARD T, YELESWARAPU KOTESWAR R, PAL MANOJIT, KUMAR POTLAPALLY R, ALLURI SESHA S, ALEXANDER CHRISTOPHER W, REDDY JANGALGAR T, REDDY VELAGALA VENKATA RAMA M.K, PILLARISETTI SIVARAM, REDDY GADDAM O
Format Patent
LanguageEnglish
Published 16.11.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.
Bibliography:Application Number: US20060441326